Browse > Article
http://dx.doi.org/10.5115/acb.2010.43.4.284

HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression  

Kim, Sin-Do (Department of Anatomy, Chonnam National University Medical School)
Park, Ra-Young (Department of Anatomy, Chonnam National University Medical School)
Kim, Young-Rang (Department of Anatomy, Chonnam National University Medical School)
Kim, In-Je (Department of Anatomy, Chonnam National University Medical School)
Kang, Taek-Won (Department of Urology, Chonnam National University Medical School)
Nam, Kwang-Il (Department of Anatomy, Chonnam National University Medical School)
Ahn, Kyu-Youn (Department of Anatomy, Chonnam National University Medical School)
Bae, Choon-Sang (Department of Anatomy, Chonnam National University Medical School)
Kim, Baik-Youn (Department of Anatomy, Chonnam National University Medical School)
Park, Sung-Sik (Department of Anatomy, Chonnam National University Medical School)
Jung, Chae-Yong (Department of Anatomy, Chonnam National University Medical School)
Publication Information
Anatomy and Cell Biology / v.43, no.4, 2010 , pp. 284-293 More about this Journal
Abstract
During the prostate cancer (PCa) development and its progression into hormone independency, androgen receptor (AR) signals play a central role by triggering the regulation of target genes, including prostate-specific antigen. However, the regulation of these AR-mediated target genes is not fully understood. We have previously demonstrated a unique role of HOXB13 homeodomain protein as an AR repressor. Expression of HOXB13 was highly restricted to the prostate and its suppression dramatically increased hormone-activated AR transactivation, suggesting that prostate-specific HOXB13 was a highly potent transcriptional regulator. In this report, we demonstrated the action mechanism of HOXB13 as an AR repressor. HOXB13 suppressed androgen-stimulated AR activity by interacting with AR. HOXB13 did neither bind to AR responsive elements nor disturb nuclear translocation of AR in response to androgen. In PCa specimen, we also observed mutual expression pattern of HOXB13 and AR. These results suggest that HOXB13 not only serve as a DNA-bound transcription factor but play an important role as an AR-interacting repressor to modulate hormone-activated androgen receptor signals. Further extensive studies will uncover a novel mechanism for regulating AR-signaling pathway to lead to expose new role of HOXB13 as a non-DNA-binding transcriptional repressor.
Keywords
HOX; HOXB13; Androgen receptor; Prostate cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lagorce-Pages C, Paraf F, Dubois S, Belghiti J, Flejou JF. (1998). Expression of CD44 in premalignant and malignant Barrett's oesophagus. Histopathology 32: 7-14   DOI   ScienceOn
2 Zappavigna V, Sartori D, Mavilio F. (1994). Specificity of HOX protein function depends on DNA-protein and protein-protein interactions, both mediated by the homeo domain. Genes Dev 8: 732-744   DOI   ScienceOn
3 Lee SJ, Lee K, Yang X, et al. (2003). NFATc1 with AP-3 site binding specificity mediates gene expression of prostate-specific-membrane-antigen. J Mol Biol 330: 749-760   DOI   ScienceOn
4 Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. (2004b). HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res 64: 9185-9192   DOI   ScienceOn
5 Kim YR, Oh KJ, Park RY, et al. (2010). HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling. Mol Cancer 9: 124   DOI   ScienceOn
6 Jung C, Kim RS, Lee SJ, Wang C, Jeng MH. (2004a). HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res 64: 3046-3051   DOI   ScienceOn
7 Economides KD, Zeltser L, Capecchi MR. (2003). Hoxb13 mutations cause overgrowth of caudal spinal cord and tail vertebrae. Dev Biol 256: 317-330   DOI   ScienceOn
8 Edwards S, Campbell C, Flohr P, et al. (2005). Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer 92: 376-381   DOI   ScienceOn
9 Hood L, Heath JR, Phelps ME, Lin B. (2004). Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643   DOI   ScienceOn
10 Catron KM, Zhang H, Marshall SC, Inostroza JA, Wilson JM, Abate C. (1995). Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol Cell Biol 15: 861-871   DOI
11 Chariot A, van Lint C, Chapelier M, Gielen J, Merville MP, Bours V. (1999). CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene 18: 4007-4014   DOI   ScienceOn
12 Economides KD, Capecchi MR. (2003). Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130: 2061-2069   DOI   ScienceOn
13 Wimmel A, Kogan E, Ramaswamy A, Schuermann M. (2001). Variant expression of CD44 in preneoplastic lesions of the lung. Cancer 92: 1231-1236   DOI   ScienceOn
14 Zeltser L, Desplan C, Heintz N. (1996). Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122: 2475-2484
15 Shen WF, Montgomery JC, Rozenfeld S, et al. (1997). AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol Cell Biol 17: 6448-6458   DOI
16 Sreenath T, Orosz A, Fujita K, Bieberich CJ. (1999). Androgen-independent expression of hoxb-13 in the mouse prostate. Prostate 41: 203-207   DOI   ScienceOn
17 Takahashi Y, Hamada J, Murakawa K, et al. (2004). Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 293: 144-153   DOI   ScienceOn
18 Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dolle P. (1997). Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124: 4781-4791
19 Shen W, Chrobak D, Krishnan K, Lawrence HJ, Largman C. (2004). HOXB6 protein is bound to CREB-binding protein and represses globin expression in a DNA binding-dependent, PBX interaction-independent process. J Biol Chem 279: 39895-39904   DOI   ScienceOn
20 Shen WF, Chang CP, Rozenfeld S, et al. (1996). Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA. Nucleic Acids Res 24: 898-906   DOI   ScienceOn
21 Shen WF, Krishnan K, Lawrence HJ, Largman C. (2001). The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol 21: 7509-7522   DOI   ScienceOn
22 Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S. (2000b). HOXA5 regulates expression of the progesterone receptor. J Biol Chem 275: 26551-26555   DOI   ScienceOn
23 Schnabel CA, Abate-Shen C. (1996). Repression by HoxA7 is mediated by the homeodomain and the modulatory action of its N-terminal-arm residues. Mol Cell Biol 16: 2678-2688   DOI
24 Prins GS, Birch L, Habermann H, et al. (2001). Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 13: 241-252   DOI   ScienceOn
25 Raman V, Martensen SA, Reisman D, et al. (2000a). Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405: 974-978   DOI   ScienceOn
26 Podlasek CA, Seo RM, Clemens JQ, Ma L, Maas RL, Bushman W. (1999b). Hoxa-10 deficient male mice exhibit abnormal development of the accessory sex organs. Dev Dyn 214: 1-12   DOI   ScienceOn
27 Podlasek CA, Duboule D, Bushman W. (1997). Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn 208: 454-465   DOI   ScienceOn
28 Levine M, Hoey T. (1988). Homeobox proteins as sequence-specific transcription factors. Cell 55: 537-540   DOI   ScienceOn
29 Mann RS, Chan SK. (1996). Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteins. Trends Genet 12: 258-262   DOI   ScienceOn
30 Podlasek CA, Clemens JQ, Bushman W. (1999a). Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J Urol 161: 1655-1661   DOI   ScienceOn
31 Lee SJ, Kim HS, Yu R, et al. (2002). Novel prostate-specific promoter derived from PSA and PSMA enhancers. Mol Ther 6: 415-421   DOI   ScienceOn